U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07200674) titled 'Interest of High-speed Centrifugation for Measuring Anti-Xa Activity on Lipemic Plasma' on March 26.
Brief Summary: Some hemostasis techniques require spectrophotometric measurements. These are then subject to interference from the sample's lipemia (postprandial, hypertriglyceridemia, etc.), which risks distorting the results; this is estimated to affect 0.5 to 2.5% of samples.
This is particularly the case for anti-Xa activity, a critical test used to monitor anticoagulant treatments.
To date, the HUS Hematology Laboratory does not have or is aware of any alternative method to overcome this interference, and is unable to perform a...